1.43 USD
↘ 0.10 (6.54%)AT CLOSE (11:59 AM EDT)
MetaVia Inc. Common Stock
MTVANASDAQ • USD
1.45
↗ 0.02 (1.12%)
POST MARKET (AS OF 07:46 PM EDT)
Post Market
AS OF 07:46 PM EDT
1.45
↗ 0.02 (1.12%)
Market: CLOSED
MetaVia Inc. Common Stock (MTVA) trades at $1.43 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest MTVA is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 26, 2026.
Open?$1.50
High?$1.54
Low?$1.41
Prev. Close?$1.53
Volume?99.7K
Avg. Volume?7.6M
VWAP?$1.49
Rel. Volume?0.01x
Bid / Ask
Bid?$1.22 × 100
Ask?$1.67 × 100
Spread?$0.45
Midpoint?$1.44
Valuation & Ratios
Market Cap?7.4M
Shares Out?5.2M
Float?3.4M
Float %?65.2%
P/E Ratio?N/A
P/B Ratio?0.81
EPS?-$2.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.
Address
545 CONCORD AVENUE
CAMBRIDGE, MA 02138
Phone: (857) 702-9600
CAMBRIDGE, MA 02138
Phone: (857) 702-9600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?73
Piotroski F-Score?0/9Weak
Altman Z-Score?-16.45Distress
Confidence?38%Very Low
Short InterestHigh
Short % of Float?12.32%High
Short Interest?414.8K
Days to Cover?1.0
Free Float3.4M
Avg Daily Volume2.0M
Settlement Date2026-06-15
Financial Health
Current Ratio?2.73Strong
Quick Ratio?2.73Strong
Cash Ratio?2.64Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.81CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.5CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-144.7%WEAK▾
S&P3
ROA?-91.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15146000
Enterprise Value?$-6326951
Fundamentals ratios updated end of day